WELLS FARGO & COMPANY/MN - NEUROONE MED TECHNOLOGIES CO ownership

NEUROONE MED TECHNOLOGIES CO's ticker is NMTC and the CUSIP is 64130M209. A total of 21 filers reported holding NEUROONE MED TECHNOLOGIES CO in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NEUROONE MED TECHNOLOGIES CO
ValueSharesWeighting
Q3 2023$148
+3.5%
166
+39.5%
0.00%
Q2 2023$143
-16.4%
119
+12.3%
0.00%
Q1 2023$171
+36.8%
106
+1.9%
0.00%
Q4 2022$125104
+3.0%
0.00%
Q3 2022$0101
+16.1%
0.00%
Q2 2022$087
+8.8%
0.00%
Q1 2022$080
+3.9%
0.00%
Q4 2021$077
+42.6%
0.00%
Q3 2021$0540.00%
Other shareholders
NEUROONE MED TECHNOLOGIES CO shareholders Q3 2023
NameSharesValueWeighting ↓
Mayo Clinic 181,754$161,8340.31%
PERKINS CAPITAL MANAGEMENT INC 150,000$1340.13%
Nantahala Capital Management 1,250,000$1,113,0000.10%
Princeton Global Asset Management LLC 16,833$14,9880.00%
MAI Capital Management 50,000$44,5200.00%
SG Americas Securities, LLC 50,453$450.00%
Walleye Capital LLC 225,956$201,1910.00%
UBS Group AG 108$960.00%
NewEdge Advisors, LLC 2,380$2,1190.00%
OSAIC HOLDINGS, INC. 700$6230.00%
View complete list of NEUROONE MED TECHNOLOGIES CO shareholders